Adjuvant endocrine therapy for premenopausal women with early breast cancer

被引：52
作者：
Dellapasqua, S
Colleoni, M
Gelber, RD
Goldhirsch, A
机构：
[1] European Inst Oncol, Div Med Oncol, Dept Med, I-20141 Milan, Italy
[2] Int Breast Canc Study Grp Coordinating Ctr, Bern, Switzerland
[3] Oncol Inst So Switzerland, Bellinzona, Switzerland
[4] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Int Breast Canc Study Grp Stat Ctr, Boston, MA 02115 USA
[5] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期
关键词：
D O I：
10.1200/JCO.2005.11.050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1736 / 1750
页数：15
相关论文
共 100 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
Abe O, 1998, LANCET, V352, P930
[3]   Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? [J].
Aebi, S ;
Gelber, S ;
Castiglione-Gertsch, M ;
Gelber, RD ;
Collins, J ;
Thürlimann, B ;
Rudenstam, CM ;
Lindtner, J ;
Crivellari, D ;
Cortes-Funes, H ;
Simoncini, E ;
Werner, ID ;
Coates, AS ;
Goldhirsch, A .
LANCET, 2000, 355 (9218) :1869-1874
[4]   Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy.: Report from the Danish Breast Cancer Co-Operative Group DBCG 82B trial [J].
Andersson, M ;
Kamby, C ;
Jensen, MB ;
Mouridsen, H ;
Ejlertsen, B ;
Dombernowsky, P ;
Rose, C ;
Cold, S ;
Overgaard, M ;
Andersen, J ;
Kjær, M .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (12) :1659-1666
[5]  
[Anonymous], 1996, Lancet, V348, P1189
[6]  
[Anonymous], 1993, Lancet, V341, P1293
[7]  
[Anonymous], P AM SOC CLIN ONCOL
[8]  
[Anonymous], P ASCO
[9]  
ARRIAGADA R, 2003, P AN M AM SOC CLIN, V22, P4
[10]  
BAUM M, 1988, BRIT J CANCER, V57, P608
12345678910